New tests suggest how a contaminant in heparin -- a blood thinner -- may be connected to dozens of deaths, FDA officials said Monday. The Food and Drug Administration has "now established a mechanism by which we think this contaminant could cause these adverse events," said Dr. Janet Woodcock, director of the FDA's Center for Drug Evaluation and Research. Changzhou SPL Co. Ltd. The FDA posted on its Web site a warning letter to Changzhou SPL. Germany and the United States are the only countries that have linked adverse events to the drug, but cases in other countries may have gone unnoticed, Woodcock said. Though Chinese officials have raised the possibility that clean and safe heparin may have also been linked to adverse events, Woodcock discounted that.